a month ago
TRVI
AnalystsDebanjana ChatterjeeDebanjana Chatterjee's Stock Forecasts
AnalystsDebanjana Chatterjee
Sectors:
Industries:
Analyst Ranking
Top 24%
#1314 out of 5510 analysts
Average Return
+20.55%
Win Rate
55%11 out of 20
Risk vs Reward
Poor
Good
Debanjana Chatterjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | +216.12% | $28.66 | $90.60 | 2025-12-01 - 2026-09-11 | Strong Buy |
Abcellera Biologics IncABCL | +207.63% | $3.54 | $10.89 | 2026-04-10 - 2026-09-11 | Strong Buy |
Contineum Therapeutics IncCTNM | +94.12% | $7.14 | $13.86 | 2025-03-13 - 2026-03-12 | Strong Buy |
Theravance Biopharma IncTBPH | +57.45% | $10.60 | $16.69 | 2025-06-17 - 2026-06-16 | Strong Buy |
Trevi Therapeutics IncTRVI | +48.60% | $10.70 | $15.90 | 2026-03-19 - 2026-09-11 | Strong Buy |
Debanjana Chatterjee Analyst Color
Get additional color on Debanjana Chatterjee's coverage of popular stocks
5 months ago
SYRE
Debanjana Chatterjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Trevi Therapeutics IncTRVI | 2 | Strong Buy | $28.00 | +76.10% | Maintains | a month ago |
Alterity Therapeutics LtdATHE | 1 | Strong Buy | $16.00 | +295.06% | Initiates Coverage On | 2 months ago |
Theravance Biopharma IncTBPH | 2 | Hold | N/A | N/A | Downgrades | 3 months ago |
Sionna Therapeutics IncSION | 2 | Strong Buy | $63.00 | +702.55% | Maintains | 5 months ago |
Spyre Therapeutics IncSYRE | 3 | Strong Buy | $95.00 | +4.86% | Maintains | 5 months ago |
Mindwalk Holdings CorpHYFT | 1 | Strong Buy | $5.00 | +283.14% | Initiates Coverage On | 5 months ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $11.00 | +1.01% | Initiates Coverage On | 5 months ago |
Intellia Therapeutics IncNTLA | 3 | Strong Buy | $29.00 | +147.02% | Upgrades | 6 months ago |
Armata Pharmaceuticals IncARMP | 1 | Strong Buy | $15.00 | +178.81% | Initiates Coverage On | 8 months ago |
Sagimet Biosciences IncSGMT | 2 | Strong Buy | $27.00 | N/A | Maintains | a year ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $39.00 | N/A | Initiates Coverage On | a year ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 2 years ago |
Pharvaris NvPHVS | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.